By Adam Lidgett ( July 9, 2019, 6:39 PM EDT) -- Germany-based BioNTech, which works on personalized treatments for diseases like cancer, said Tuesday that it has finished up a $325 million funding round guided by Freshfields, calling it one of the biggest single rounds for a European biotechnology company ever recorded....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.